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The culture medium of certain strains of Clostridium botulinum type C contains two separable ADP-ribosyl- 
transferases. Besides the ADP-ribosylation of actin due to botulinurn C2 I toxin, a second microbial enzyme 
causes the mono-ADP-ribosylation of a eukaryotic protein with a molecular mass of about 20 kDa found 
in platelets, neuroblastoma x glioma hybrid cells, S49 lymphoma cells, chick embryo fibroblasts and sperm. 
The eukaryotic substrate is inactivated by heating and trypsin treatment. In contrast, the novel ADP-ribo- 
syltransferase, which can be separated by DEAE-Sephadex chromatography, is largely resistant in the short 
term to trypsin digestion. 
ADP-ribosyltransferase; Botulinum C2 toxin; (Clostridium botufinum) 
1. INTRODUCTION 2. MATERIALS AND METHODS 
ADP-ribosylation of regulatory proteins is an 2.1. Materials 
important pathophysiological mechanism by 
which bacterial toxins such as cholera toxin, per- 
tussis toxin and diphtheria toxin affect eukaryotic 
cell functions [l-3]. Botulinurn C2 toxin, pro- 
duced by certain strains of Clostridium botulinum 
type C, is another bacterial toxin, which possesses 
ADP-ribosyltransferase activity [4-61. Recently, 
we have shown that the enzymatically active com- 
ponent I of botulinurn C2 toxin ADP-ribosylates 
non-muscle actin [5,6], leading to drastic changes 
in the functional properties of actin. In the present 
communication we report that in addition to 
botulinurn C2 toxin certain strains of Clostridium 
botulinum type C produce another ADP- 
ribosyltransferase, whose eukaryotic substrate is 
clearly distinct from actin, the target of botulinurn 
C2 toxin. 
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All chemicals were of analytical grade and were 
obtained from sources already described elsewhere 
[6]. Clostridium botulinurn type C strain 486c was 
donated by Dr Sebald, Pasteur Institut, Paris. The 
culture medium consisted of 3% peptone from 
meat (tryptic digest), 2% yeast extract, 0.5% 
glucose, and 0.1% cysteine hydrochloride (all from 
Merck, Darmstadt, FRG). Before autoclaving the 
pH of the medium was adjusted to pH 7.2. The 
cultures were grown under anaerobic condition us- 
ing a BBL gas-pack system. After incubation for 4 
days at 37”C, the cell-free culture supernatant was 
obtained by centrifugation and subsequent filtra- 
tion through 0.45 pm Millipore filter. Botulinurn 
C2 toxin was purified according to Ohishi et al. 
[71. 
2.2. ADP-ribosylation assay 
ADP-ribosylation of eukaryotic proteins was 
performed essentially as described [6]. Briefly, the 
ADP-ribosylation medium contained 10 mM 
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thymidine, 0.5 mM MgC12, 0.5 mM ATP, 
0.1-l PM [32P]NAD (about 0.5-l &i/tube) and 
50 mM triethanolamine-HCl, pH 7.5. The incuba- 
tion was performed for the indicated time at 37°C 
in a total volume of 100 ,ul. The protein concentra- 
tion was 20-lOOpg/tube. The concentration of 
botulinum C2 toxin was 1 pug/ml. The amount of 
added bacterial culture medium or purified ADP- 
ribosyltransferase preparation was as indicated. 
Determination of the ADP-ribosyltransferase ac- 
tivity was performed by stopping the reaction with 
400 ~1 SDS (2%, w/v), BSA (1 mg/ml) and 
precipitation of the proteins with 500~1 
trichloroacetic acid (30%, w/v). Proteins were col- 
lected onto nitrocellulose filters. The filters were 
washed 10 times with 2 ml of 6% trichloroacetic 
acid and placed in scintillation fluid for analysis of 
retained radioactivity. 
2.3. Analysis of the labelled proteins 
After the indicated incubation time the ADP- 
ribosylation reaction was stopped by the addition 
of 1 ml trichloroacetic acid (20%, w/v). The resul- 
tant pellet was washed with ether, dissolved in 
50 ~1 electrophoresis buffer and analyzed by SDS- 
polyacrylamide gel electrophoresis according to 
Laemmli [S]. Gels were stained, destained and sub- 
jected to autoradiography. 
2.4. Trypsin treatment 
For trypsin treatment purified ADP- 
ribosyltransferase (about 2pg of protein) or 
platelet membranes (about 5Opg of protein) were 
incubated in the presence of 0.1 mg/ml trypsin for 
10 min at 37°C. The reaction was stopped by the 
addition of soybean trypsin inhibitor (1 mg/ml 
final concentration). For control conditions the 
ADP-ribosyltransferase or platelet membranes 
were incubated in the presence of both trypsin and 
soybean trypsin inhibitor before carrying out the 
ADP-ribosylation reaction. 
2.5. Purification of the second ADP-ribosyl- 
transferase 
50 ml of culture medium was precipitated by the 
addition of 19 g (NH&S04. After 12 h the formed 
precipitate was collected by centrifugation and 
dissolved in 20 ml of 100 mM Tris-HCl, pH 7.5. 
The solution was dialyzed againsst 50 mM Tris- 
HCl, pH 7.5 and applied to a DEAE-Sephadex col- 
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umn (1.5 x 5 cm). The column was washed with 
50 ml of the same buffer and eluted with 20 ml of 
50 mM Tris-HCI (pH 7.5) containing 300 or 
400 mM NaCl. The nonbound fraction contained 
the ADP-ribosyltransferase, which labelled the 
20 kDa protein, the eluate contained the 
botulinum C2 toxin. The concentrated nonbound 
fraction of the DEAE-column was injected into a 
Waters HPLC, composed of a UK6 injector, a 
6000 A pump and a Pye Unicam absorbance detec- 
tor (LC-UV, 280 nm) in 200 mM phosphate buffer 
(pH 7) at a flow rate of 0.5 ml/min. Proteins were 
separated on a Zorbax Du Pont 9, 4 x 250 mm, 
GF-250. The fraction size was 210~1. 
3. RESULTS AND DISCUSSION 
In lysates of human platelet membranes and 
with [32P]NAD, filtrates of culture medium of 
Ciostridium botulinurn type C strain 486c labelled 
two different proteins with relative molecular 
masses of about 43 and 20 kDa, respectively 
(fig.l,I). The labelled 43 kDa protein was actin 
ADP-ribosylated by botulinum C2 toxin [5,6], 
which is produced by this strain of Clostridium 
botulinurn. The labelling of the 20 kDa substrate 
was also caused by an ADP-ribosylation and not 
by mere phosphorylation, because the labelling 
was readily abolished in the presence of 100 PM 
unlabelled NAD but not with 0.5 mM ATP, which 
was always present in the reaction mixture 
(fig. 1 ,II). Labelling of the 20 kDa substrate was a 
time-dependent process and reached a maximum 
after an incubation time of 20 min (fig.2). Similar- 
ly, as found for the ADP-ribosylation of actin by 
botulinurn C2 toxin [6], the labelling of the 20 kDa 
substrate was apparently due to a mono-ADP- 
ribosylation. This conclusion can be drawn from 
the finding that the total amount of label increased 
with time, but was not accompanied by a concomi- 
tant increase in the apparent molecular weight of 
the labelled substrate. The proteinaceous nature of 
the 20 kDa substrate was shown by studying the ef- 
fects of trypsin treatment of crude platelet mem- 
branes on the ADP-ribosylation reaction. When 
platelet membranes were pretreated with trypsin 
(100 ,ug/ml), the labelling of the 20 kDa substrate 
was completely abolished (fig.2). Also heating of 
platelet membranes for 10 min at 95°C prevented 
the subsequent ADP-ribosylation of the 20 kDa 
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Fig.1. (I) ADP-ribosylation of crude human platelet 
membranes by clostridia culture medium. Crude human 
platelet membranes (8Opg of protein) were incubated 
with [32P]NAD (0.1 PM, about 0.5 &i) and 10~1 of 
Clostridium botulinurn culture filtrate for 30 min at 
37°C as described in section 2. The autoradiogram of the 
SDS-polyacrylamide gel of the labelled proteins is 
shown. The A4, markers were bovine serum albumin (Mr 
66000), ovalbumin (Mr 45000), glyceraldehyde-3-phos- 
phate dehydrogenase (Mr 36000), carbonic anhydrase 
(Mr 29000), trypsinogen (A4r 24000), soybean trypsin 
inhibitor (j% 20000), c-lactalbumin (MI 14200). (II) 
Effects of NAD on the ADP-ribosylation of the 20 kDa 
substrate in neuroblastoma x glioma hybrid cell mem- 
branes. Crude neuroblastoma x glioma hybrid cell 
membranes (25 cg of protein) were incubated with 
0.1 PM [32P]NAD (0.1 PM, about 1 PCi), without 
(control) and with 3 ~1 of purified botulinum ADP- 
ribosyltransferase preparation (C3, DEAE-column 
flowthrough, 0.5 ,ug of protein) in the absence and 
presence of NAD (100,~M) for 30 min at 37°C. There- 
after polyacrylamide gel electrophoresis of the platelet 
proteins and autoradiography (shown) of the labelled 
proteins were performed. 
protein (fig.2). The labelling of the 20 kDa protein 
was also found in membrane preparations of 
neuroblastoma x glioma hybrid cells, S49 lym- 
phoma cells, chick embryo fibroblasts and sperm 
(not shown). In order to clarify whether the 
20 kDa substrate was also a target of botulinum 
C2 toxin or whether a different ADP- 
ribosyltransferase was involved, we purified the 
ADP-ribosyltransferases found in the culture 
medium. The extract of an ammonium sulfate 
Fig.2. ADP-ribosylation of the 20 kDa protein in 
platelet membranes by the botulinum ADP- 
ribosyltransferase. (I) Time course of the ADP- 
ribosylation of the 20 kDa protein. Crude human 
platelet membranes were incubated with [32P]NAD and 
2 pl of purified botulinum ADP-ribosyltransferase 
(DEAE-column flowthrough, 0.3 pg protein) for the 
indicated times. (II) Effects of trypsin treatment and 
heating of platelet membranes on the subsequent ADP- 
ribosylation of the 20 kDa protein. Crude platelet 
membranes were heated for 10 min at 95°C (A) or 
treated with trypsin (B, 100 gg/ml) or with trypsin plus 
trypsin-inhibitor as control (C, 1 mg/ml). Thereafter the 
ADP-ribosylation of the 20 kDa platelet membrane 
protein was performed with [32P]NAD (0.1 pM, 1 &i) 
and 2 ~1 of the purified botulinum ADP- 
ribosyltransferase. 
precipitation of the culture medium was able to 
ADP-ribosylate both substrates (not shown). 
However, further purification by means of DEAE- 
Sephadex clearly separated the two ADP- 
ribosyltransferase activities. The DEAE-Sephadex 
column flowthrough contained the enzyme for 
ADP-ribosylation of the 20 kDa substrate, 
whereas the activity for ADP-ribosylation of the 
43 kDa substrate was retained on the DEAE col- 
umn (fig.3,I). The labelling of the 43 kDa protein 
was evidently due to botulinum C2 toxin, which is 
known to adsorb to DEAE under the conditions 
used [7]. This notion was substantiated by the fin- 
ding that the DEAE column eluate but not the 
flowthrough was able to ADP-ribosylate isolated 
platelet G-actin (not shown). SDS-polyacrylamide 
gel electrophoresis of the DEAE column 
flowthrough showed one major protein band with 
a molecular mass of about 24 kDa (fig.3,II). In 
order to purify further the ADP-ribosyltransferase 
involved in the ADP-ribosylation of the 20 kDa 
protein, we concentrated the unadsorbed fraction 
of the DEAE column and applied it to gel filtration 
on a GF 250 column. As shown in fig.4 the en- 
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Fig.3. (I) DEAE-Sephadex chromatography of 
botulinum C2 toxin and of a second botulinum ADP- 
ribosyltransferase. DEAE-Sephadex chromatography 
was performed according to the procedure described in 
section 2. For determination of the ADP-ribosyltrans- 
ferase activity 1 rg/ml purified botulinum C2 toxin (A), 
10 ~1 of the culture medium filtrate (B), lop1 of the 
DEAE-Sephadex column flowthrough (C), 10111 of the 
column wash (D, 50 mM Tris-HCl, pH 7.5) and 10~1 of 
the fractions eluted with 50 mM Tris-HCI and 300 mM 
NaCl (E-J) were incubated with platelet lysate (30 cg of 
protein) and [‘*PINAD (0.2pM, about 0.5 pCi) for 
30 min at 37°C. The autoradiogram of the labelled 
platelet lysate proteins after SDS gel electrophoresis is 
shown. (II) SDS-polyacrylamide gel analysis of the 
purified botulinurn ADP-ribosyltransferase C3. The 
botulinum ADP-ribosyltransferase responsible for 
labelling of the 20 kDa eukaryotic membrane protein 
was purified as described in section 2. An SDS-poly- 
acrylamide gel of the concentrated DEAE-Sephadex 
column flowthrough (about 1Opg of protein) is shown. 
zymatic activity, which causes ADP-ribosylation 
of the 21 kDa substrate, eluted in a fraction cor- 
responding with a molecular mass of about 
12-20 kDa. When the fractions containing the en- 
zymatic activity were further analyzed by SDS gel 
electrophoresis, a protein with a relative molecular 
mass of 24 kDa was detected by means of silver 
staining. Thus, this ADP-ribosyltransferase, for 
which we propose the term ‘C3’, is clearly distinct 
from botulinurn C2 toxin, whose molecular mass is 
about 50 kDa [8]. The relative molecular mass of 
the ADP-ribosyltransferase C3 was slightly larger 
than that of the eukaryotic substrate determined 
by means of SDS gel electrophoresis. Fig.5 shows 
that the labelling of the substrate by C3 largely in- 
creased on addition of increasing amounts of 
platelet membranes to the reaction mixture. In 
contrast, labelling of the 20 kDa substrate was not 
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Fig.4. ADP-ribosylation of a 20 kDa platelet membrane 
protein by the botulinum ADP-ribosyltransferase C3 
purified by HPLC. The concentrated DEAE-column 
breakthrough was applied to gel filtration by HPLC. 
The ADP-ribosyltransferase activity of each fraction 
was determined with [32P]NAD (0.1 PM, about 0.3 pCi) 
and crude platelet membranes (50 pug of proteins) by the 
filtration method as described in section 2. The labelled 
proteins were analyzed by SDS-polyacrylamide gel 
electrophoresis and autoradiography (shown). 
further enhanced by increasing the concentration 
of the microbial ADP-ribosyltransferase from 2 up 
to 20pg/ml (not shown). These findings indicate 
that a eukaryotic substrate in platelet membranes 
but not the microbial enzyme itself was ADP- 
ribosylated. This notion was further supported by 
the finding that in contrast to the 20 kDa substrate 
protein, the ADP-ribosyltransferase C3 was large- 
ly stable against trypsin treatment (not shown). 
Taken together, the culture medium of 
Clostridium botulinum type C contains two ADP- 
ribosyltranferases. One enzyme is botulinurn C2 
toxin, which ADP-ribosylates non-muscle G-actin 
[5,6]. The second ADP-ribosyltransferase, which 
is clearly distinct from botulinum C2 toxin, has a 
relative molecular mass of about 24 kDa on SDS 
gel and ADP-ribosylates a eukaryotic protein 
substrate of about 20 kDa. We propose the term 
C3 for this ADP-ribosyltransferase to distinguish 
this newly found enzyme from botulinum 
neurotoxin Cl and botulinurn C2 toxin, which are 
also produced by this strain of Clostridium 
botulinurn. In order to obtain more insights into 
the role of this newly found bacterial ADP- 
ribosyltransferase we are now studying the nature 
and function of the 20 kDa eukaryotic substrate. 
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